CUDC-907, a dual PI3K and HDAC inhibitor, has been shown to suppress the growth of MYC-driven neuroblastoma and medulloblastoma and to exhibit radiosensitizing properties in DMG models by inhibiting radiation-induced DDR pathways [230,231,232]. The gene discussed is MYC; the disease is medulloblastoma.